• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丙型肝炎病毒感染与糖尿病风险:一项基于社区的前瞻性研究。

Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study.

机构信息

Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

Genomics Research Center, Academia Sinica, Taipei, Taiwan.

出版信息

Liver Int. 2017 Feb;37(2):179-186. doi: 10.1111/liv.13194. Epub 2016 Jul 21.

DOI:10.1111/liv.13194
PMID:27363856
Abstract

BACKGROUND

The association between hepatitis C virus (HCV) infection and the occurrence of type II diabetes remains controversial. Prospective studies are needed to assess its causal temporality.

METHODS

A cohort of 21 559 adults enrolled from seven townships in Taiwan during 1991-1992 and followed till the end of 2010. Incident diabetes over a study time period from 2000 to 2010 was ascertained through computerized linkage with the National Health Insurance database and the National Death Certification profiles. Cox's proportional hazards models were used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). Antibodies against HCV (anti-HCV) were tested for all participants, and serum HCV RNA levels were measured for anti-HCV seropositives.

RESULTS

During 180 244 person-years of follow-up, there were 1917 incident diabetes cases recorded. The cumulative risk for diabetes was 10.9% for anti-HCV seronegatives and 16.7% for anti-HCV seropositives respectively. The HR for diabetes of anti-HCV seropositivity was 1.53 (95% CI: 1.29-1.81) compared with anti-HCV seronegatives after adjustment for risk predictors. The adjusted HRs were 1.63 (1.31-2.02) for anti-HCV seropositives with positive HCV RNA compared to anti-HCV seronegatives (P<.001).

CONCLUSION

Chronic HCV infection was associated with an increased risk for diabetes after adjustment for other risk predictors.

摘要

背景

丙型肝炎病毒(HCV)感染与 2 型糖尿病发生之间的关联仍存在争议。需要前瞻性研究来评估其因果关系的时间顺序。

方法

1991 年至 1992 年期间,在台湾的七个乡镇招募了 21559 名成年人,并随访至 2010 年底。通过与国家健康保险数据库和国家死亡证明档案的计算机链接,确定了 2000 年至 2010 年研究期间的新发糖尿病病例。使用 Cox 比例风险模型估计风险比(HR)及其 95%置信区间(CI)。对所有参与者进行丙型肝炎病毒抗体(抗-HCV)检测,并对抗-HCV 血清阳性者检测血清 HCV RNA 水平。

结果

在 180244 人年的随访期间,记录了 1917 例新发糖尿病病例。抗-HCV 血清阴性者的糖尿病累积风险为 10.9%,抗-HCV 血清阳性者为 16.7%。抗-HCV 血清阳性者患糖尿病的风险比(HR)为 1.53(95%CI:1.29-1.81),与抗-HCV 血清阴性者相比,调整了风险预测因素后。与抗-HCV 血清阴性者相比,抗-HCV 血清阳性且 HCV RNA 阳性者的调整 HR 为 1.63(1.31-2.02)(P<.001)。

结论

在调整了其他风险预测因素后,慢性 HCV 感染与糖尿病风险增加相关。

相似文献

1
Chronic hepatitis C virus infection and the risk for diabetes: a community-based prospective study.慢性丙型肝炎病毒感染与糖尿病风险:一项基于社区的前瞻性研究。
Liver Int. 2017 Feb;37(2):179-186. doi: 10.1111/liv.13194. Epub 2016 Jul 21.
2
Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study.慢性丙型肝炎病毒感染增加肝脏和肝外疾病导致的死亡率:一项基于社区的长期前瞻性研究。
J Infect Dis. 2012 Aug 15;206(4):469-77. doi: 10.1093/infdis/jis385. Epub 2012 Jul 17.
3
Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study.丙型肝炎病毒血清标志物与随后发生肝细胞癌的风险:基于社区队列研究的长期预测指标。
J Clin Oncol. 2010 Oct 20;28(30):4587-93. doi: 10.1200/JCO.2010.29.1500. Epub 2010 Sep 20.
4
Hepatitis C viral load, genotype, and increased risk of developing end-stage renal disease: REVEAL-HCV study.丙型肝炎病毒载量、基因型与终末期肾病发病风险增加:REVEAL-HCV 研究。
Hepatology. 2017 Sep;66(3):784-793. doi: 10.1002/hep.29192. Epub 2017 Jul 18.
5
Hepatitis C virus infection and increased risk of cerebrovascular disease.丙型肝炎病毒感染与脑血管病发病风险增加。
Stroke. 2010 Dec;41(12):2894-900. doi: 10.1161/STROKEAHA.110.598136. Epub 2010 Oct 21.
6
Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.丙型肝炎病毒 1b 基因型增加了肝细胞癌的终生累积风险。
Int J Cancer. 2014 Sep 1;135(5):1119-26. doi: 10.1002/ijc.28753. Epub 2014 Feb 14.
7
Confluence of Epidemics of Hepatitis C, Diabetes, Obesity, and Chronic Kidney Disease in the United States Population.美国人口中丙型肝炎、糖尿病、肥胖症和慢性肾脏病流行的交汇。
Clin Gastroenterol Hepatol. 2017 Dec;15(12):1957-1964.e7. doi: 10.1016/j.cgh.2017.04.046. Epub 2017 Jun 1.
8
Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.2型糖尿病与肝细胞癌:一项在肝炎病毒感染高流行地区开展的队列研究
Hepatology. 2006 Jun;43(6):1295-302. doi: 10.1002/hep.21208.
9
The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.2型糖尿病对不同病毒性肝炎状态下肝细胞癌发生发展的影响。
Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):2054-60. doi: 10.1158/1055-9965.EPI-08-1131. Epub 2009 Jun 23.
10
Natural history of chronic hepatitis B REVEALed.慢性乙型肝炎的自然史被揭示。
J Gastroenterol Hepatol. 2011 Apr;26(4):628-38. doi: 10.1111/j.1440-1746.2011.06695.x.

引用本文的文献

1
Hepatocellular Carcinoma After HCV Eradication with Direct-Acting Antivirals: A Reappraisal Based on New Parameters to Assess the Persistence of Risk.直接作用抗病毒药物根除丙型肝炎病毒后发生的肝细胞癌:基于评估风险持续性新参数的重新评估
Cancers (Basel). 2025 Mar 18;17(6):1018. doi: 10.3390/cancers17061018.
2
ANGPTL4 is a potential driver of HCV-induced peripheral insulin resistance.ANGPTL4 是 HCV 诱导外周胰岛素抵抗的潜在驱动因素。
Sci Rep. 2023 Apr 25;13(1):6767. doi: 10.1038/s41598-023-33728-5.
3
Renal function trajectories in hepatitis C infection: differences between renal healthy and chronic kidney disease individuals.
丙型肝炎感染中的肾功能轨迹:肾功能正常者和慢性肾脏病患者之间的差异。
Sci Rep. 2021 Aug 25;11(1):17197. doi: 10.1038/s41598-021-96782-x.
4
Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.免疫标志物与乙型肝炎病毒和丙型肝炎病毒感染者发生肝细胞癌的风险。
Aliment Pharmacol Ther. 2021 Sep;54(6):833-842. doi: 10.1111/apt.16524. Epub 2021 Jul 19.
5
Strategy for the Micro-Elimination of Hepatitis C among Patients with Diabetes Mellitus-A Hospital-Based Experience.糖尿病患者丙型肝炎微观消除策略——基于医院的经验
J Clin Med. 2021 Jun 6;10(11):2509. doi: 10.3390/jcm10112509.
6
Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia.HCV 感染和种族对 2 型糖尿病发病的影响:不列颠哥伦比亚省大型基于人群队列的研究结果。
BMJ Open Diabetes Res Care. 2021 Jun;9(1). doi: 10.1136/bmjdrc-2021-002145.
7
Eradication of hepatitis C virus with direct-acting antivirals improves glycemic control in diabetes: A multicenter study.直接作用抗病毒药物根除丙型肝炎病毒可改善糖尿病患者的血糖控制:一项多中心研究。
JGH Open. 2020 Dec 19;5(2):228-234. doi: 10.1002/jgh3.12474. eCollection 2021 Feb.
8
Natural History of Hepatic and Extrahepatic Hepatitis C Virus Diseases and Impact of Interferon-Free HCV Therapy.丙型肝炎病毒肝内及肝外疾病的自然史以及无干扰素丙肝治疗的影响
Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):a036921. doi: 10.1101/cshperspect.a036921.
9
The inpatient hospital burden of comorbidities in HCV-infected patients: A population-based study in two Italian regions with high HCV endemicity (The BaCH study).慢性丙型肝炎病毒感染患者合并症的住院负担:两个高丙型肝炎流行地区的基于人群的研究(BaCH 研究)。
PLoS One. 2019 Jul 10;14(7):e0219396. doi: 10.1371/journal.pone.0219396. eCollection 2019.
10
Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients.直接作用抗病毒药物治疗可改善非糖尿病、瘦体型慢性丙型肝炎患者外周胰岛素敏感性。
PLoS One. 2019 Jun 6;14(6):e0217751. doi: 10.1371/journal.pone.0217751. eCollection 2019.